- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
Source: The post is based on the article “Pharmacopoeial Discussion Group welcomes Indian Pharmacopoeia Commission as a member” published in “PIB” on 14th October 2023
What is the News?
Indian Pharmacopoeia Commission (IPC) has joined as a member of the Pharmacopoeial Discussion Group(PDG).
IPC officially joined as a member of PDG at the PDG’s Annual Meeting in Hyderabad.
What is the Indian Pharmacopoeia Commission(IPC)?
What is Pharmacopoeial Discussion Group(PDG)?
PDG was established in 1989 by the European Union(EU), Japan and United States Pharmacopeial Convention.
The World Health Organization joined it as an observer in 2001.
Objective: To reduce the challenges faced by drug manufacturers who have to conduct tests differently and meet various quality standards to comply with drug regulations that vary from country to country.
What are the benefits of the Indian Pharmacopoeia Commission joining Pharmacopoeial Discussion Group(PDG)?
Enhances the international visibility and recognition of the Indian Pharmacopoeia.
Leads to the production of high-quality pharmaceutical products that meet global standards benefiting both domestic and export markets.
Will enable the Indian Pharmacopoeia commission to collaborate and align pharmacopoeial standards with major international regulatory authorities.
Helps improve the acceptance of Indian medicinal products in global markets.
Helps reduce trade barriers and facilitate the global trade of pharmaceutical products.
